글로벌 혈관활성 장 펩타이드 종양 시장 – 2029년까지의 산업 동향 및 예측

혈관활성 장내 펩타이드 종양 시장 분석 및 규모

글로벌 혈관활성 장 펩타이드 종양 시장은 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다. 혈관활성 장 펩타이드 종양 시장 성장을 촉진한 요인은 전 세계적으로 혈관활성 장 펩타이드 종양이 증가하고 조기 진단과 주요 시장 참여자의 R&D 활동에 대한 집중이 이 시장의 성장을 촉진할 것입니다. COVID-19도 시장 성장에 큰 영향을 미쳤습니다.

Data Bridge Market Research는 2022-2029년 예측 기간 동안 글로벌 혈관활성 장 펩타이드 종양 시장의 성장률을 분석합니다. 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자 및 시장 시나리오와 같은 시장 통찰력 외에도 Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

혈관활성 장내 펩타이드 종양 시장 범위 및 세분화

시장 정의

Vasoactive intestinal peptide tumors is a kind of pancreatic VIPoma defined as cancer arising from the cells producing hormones. In vasoactive intestinal peptide tumors, extreme production of vasoactive intestinal peptide hormone can upsurge bowel motility, abdomen pain and cramps. It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period

Global Vasoactive Intestinal Peptide Tumors Market Dynamics

Drivers

• Rapid Approval on Drugs

Presently, numerous peptide-based drugs are available in the market and have shown good results in managing a huge range of cancers. The rising interest of scientists can also be justified by the speedy approval of the first peptide-based cancer vaccine for prostate cancer treatment. Furthermore, series of new peptides with positive preclinical studies are projected to boost the market in next few years. The drugs are expected to show a pronounced clinical response compared to other cancer therapies. This boost the market growth.

• Rising Demand for Oral Drugs

Oral drugs is projected to boost the market growth. The segment is estimated to speed up the global market as many of the products are available in capsule and tablet form and it is a very feasible route of administration.

Opportunities

• Rising Healthcare Awareness

Health awareness amongst the population is rising, which results in the prediction of drugs to boost the market growth. The innovative launches in medications for treating gastric cancer are expected to prompt the market simultaneously. Different researchers are investing in launching drugs that benefit the market. This creates more opportunities in the market.

• Increasing Demand for Chemotherapy

Treatment of vasoactive intestinal peptide tumor is a multidisciplinary approach, involving the contribution of medical oncologists, surgeons, radiologists, as well as pathologists. So far, radiotherapy's role in treating gastrointestinal stromal tumor remains determinedly unestablished. Most patients suffering from this tumor choose symptomatic treatments such as conventional chemotherapy as surgery is not possible in most cases. Thus, this factor create many opportunities for the market growth.

Restraints/Challenges

• Availability of Fake Drugs

The increasing availability of fake and misbranded drugs is considered to be a significant restraint. Consequently, it can create confusion and hamper the vasoactive intestinal peptide tumor market value.

• High Cost

The huge expenditure of the treatment methods hamper the market growth. The treatment procedures such as chemotherapy, targeted therapy restrict the market growth.

This global vasoactive intestinal peptide tumors market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the g global vasoactive intestinal peptide tumors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Vasoactive Intestinal Peptide Tumors Market Scope

The global vasoactive intestinal peptide tumors market is segmented on the basis of treatment type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment Type

• Somatostatin Therapy
• Chemotherapy
• Others

Route of Administration

• Oral
• Parenteral
• Others

End-Users

• Hospitals
• Homecare
• Speciality Centres
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Vasoactive Intestinal Peptide Tumors Market Regional Analysis/Insights

The global vasoactive intestinal peptide tumors market is analysed and market size insights and trends are provided by treatment type, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global vasoactive intestinal peptide tumors market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific is expected to have the highest market growth due to the increase awareness about the diseases and rapidly disposable income.

North America dominates the market due to the increase prevalence of gastrointestinal stromal tumor, high demand of targeted therapies and advanced healthcare facilities.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 또한 글로벌 브랜드의 존재와 가용성, 그리고 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

경쟁 환경 및 글로벌 혈관활성 장 펩타이드 종양 시장 점유율 분석

글로벌 혈관활성 장 펩타이드 종양 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 글로벌 혈관활성 장 펩타이드 종양 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 혈관활성 장내 펩타이드 종양 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 마일런 NV(미국)
• Teva Pharmaceutical Industries Ltd.(이스라엘)
• 사노피(프랑스)
• 파이저 주식회사(미국)
• GSK plc (영국)
• 노바티스 AG(스위스)
• Bayer AG(독일)
• 엘리 릴리 앤드 컴퍼니(미국)
• 머크앤코(미국)
• 존슨앤존슨 프라이빗 리미티드(미국)
• 시플라 주식회사(미국)
• 애벗(미국)
• AbbVie Inc.(미국)
• Sun Pharmaceutical Industries Ltd. (인도)
• Aurobindo Pharma(인도)
• 루팡(인도)
• 히크마 제약(영국)
• Ipsen Pharma(프랑스)

SKU-54274